Reza Salajegheh, MD
Pain Medicine · Lynchburg, VANPI 1376867051
Payments from drug & device makers
What this record shows
Medtronic accounts for 74.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $2,079 and has fallen 90.2% since, to $203 in 2025.
Across 57 payments — averaging $74.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$741
- Si-bone, Inc.$204
- Abbott$129
What the payments were for
- Speaking & faculty fees$2,00047%
- Food & beverage$2,26653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 28 | $3,192 |
| Boston Scientific | 26 | $741 |
| Si-bone, Inc. | 2 | $204 |
| Abbott | 1 | $129 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$2,000
- INTELLIS ADAPTIVESTIM$538
- VECTRIS$247
- INTELLIS$190
- PROCLAIM$129
How this compares
$4,266 in reported general payments places this provider in the 70th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 791 | $13,146 |
| Gabapentin | 820 | $10,383 |
| Pregabalin | 300 | $7,595 |
| Tizanidine Hcl | 535 | $4,984 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 55 | $3,466 |
| Baclofen | 239 | $2,592 |
| Methylprednisolone | 168 | $1,038 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $783 |
| Diclofenac Sodium | 50 | $737 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 13 | $721 |
| Methocarbamol | 75 | $689 |
| Cyclobenzaprine Hcl | 68 | $642 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $524 |
| Celecoxib | 31 | $516 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $344 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lynchburg
- Ruzbeh ToussiLynchburg$5K
- Karen BurnhamLynchburg$4K
- Edward MetzgerLynchburg$3K
- Matthew RileyLynchburg$2K
- Sebastian KsionskiLynchburg$2K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.